RonTintnerMD

PubMed

• 137 citations
  Reliability of a new scale for essential tremor
  Rodger J. Elble, Cynthia L. Comella, Stanley Fahn, Mark Hallett, Joseph Jankovic, Jorge L. Juncos, Peter A. LeWitt, Kelly E. Lyons, William G. Ondo, Rajesh Pahwa, Kapi...> ;Movement Disorders. 2012 Oct 1
• 118 citations
  Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales
  Rodger J. Elble, Seth L. Pullman, Joseph Y. Matsumoto, Jan Raethjen, Günther Deuschl, Ron Tintner> ;Brain. 2006 Oct 1
• 57 citations
  Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial.
  Ron Tintner, R. Gross, U. F. Winzer, K. A. Smalky, Joseph Jankovic> ;Neurology. 2005 Sep 13
• 32 citations
  Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson disease
  Ron Tintner, Prasad Manian, Polly Gauthier, Joseph Jankovic> ;Archives of Neurology. 2005 Aug 1
• 186 citations
  Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease
  William G. Ondo, Ron Tintner, Kevin Dat Voung, Dejian Lai, George M. Ringholz> ;Movement Disorders. 2005 Aug 1
• 78 citations
  Striatal deformities of the hand and foot in Parkinson's disease.
  Ramsey Ashour, Ron Tintner, Joseph Jankovic> ;The Lancet. Neurology. 2005 Jul 1
• 26 citations
  Dopamine agonists in Parkinson's disease.
  Ron Tintner, Joseph Jankovic> ;Expert Opinion on Investigational Drugs. 2003 Nov 1
• 66 citations
  Benefits and Risks of Pharmacological Treatments for Essential Tremor
  Kelly E. Lyons, Rajesh Pahwa, Cynthia L. Comella, Mahmood S. Eisa, Rodger J. Elble, Stanley Fahn, Joseph Jankovic, Jorge L. Juncos, William C. Koller, William G. Ondo,...> ;Drug Safety. 2003 Jun 9
• 55 citations
  Tetrabenazine treatment for Huntington's disease-associated chorea
  William G. Ondo, Ron Tintner, Madhavi Thomas, Joseph Jankovic> ;Clinical Neuropharmacology. 2002 Nov 1
• 32 citations
  Treatment options for Parkinson's disease.
  Ron Tintner, Joseph Jankovic> ;Current Opinion in Neurology. 2002 Aug 10
• 12 citations
  Focal dystonia: the role of botulinum toxin.
  Ron Tintner, Joseph Jankovic> ;Current Neurology and Neuroscience Reports. 2001 Jan 1
• 89 citations
  Intrafamilial phenotypic variability of the DYT1 dystonia: From asymptomatic TOR1A gene carrier status to dystonic storm
  Puneet Opal, Ron Tintner, Joseph Jankovic, Joanne Leung, Xandra O. Breakefield, Jennifer Friedman, Laurie J. Ozelius> ;Movement Disorders. 2002 Mar 1
• 14 citations
  Botulinum toxin for the treatment of cervical dystonia
  Ron Tintner, Joseph Jankovic> ;Expert Opinion on Pharmacotherapy. 2001 Dec 17
• 75 citations
  Dystonia and parkinsonism
  Joseph Jankovic, Ron Tintner> ;Parkinsonism & Related Disorders. 2001 Oct 1
• 26 citations
  Acetylcholine receptor antibodies in the Lambert‐Eaton myasthenic syndrome
  Jonathan S. Katz, Gil I. Wolfe, Wilson W. Bryan, Ron Tintner, Richard J. Barohn> ;Neurology. 1998 Feb 1
• 15 citations
  Cognitive deficits in asymptomatic first-degree relatives of Alzheimer's disease patients
  Jim Hom, Mary B. Turner, Richard Risser, Frederick J. Bonte, Ron Tintner> ;Journal of Clinical and Experimental Neuropsychology. 1994 Aug 1
• Xenon-133 SPECT-determined regional cerebral blood flow in Alzheimer's disease: what is typical?
  W H Wighton-Benn, R Risser, D Svetlik, R Tintner, J Hom, R N Rosenberg, F J Bonte, M F Weiner> ;The Journal of Neuropsychiatry and Clinical Neurosciences. 1993 Jan 1
• 21 citations
  Experiences with depression in a dementia clinic
  M. Bruhn, Doris Svetlik, Ron Tintner, J. Hom, Myron F. Weiner> ;The Journal of Clinical Psychiatry. 1991 May 1
• 39 citations
  Single photon tomography in Alzheimer's disease and the dementias
  Frederick J. Bonte, Jim Hom, Ron Tintner, Myron F. Weiner> ;Seminars in Nuclear Medicine. 1990 Oct 1
• 7 citations
  Evaluation of quantitative measures of upper extremity speed and coordination in healthy persons and in three patient populations.
  K. Behbehani, G. V. Kondraske, Ron Tintner, R. A.S. Tindall, S. N. Imrhan> ;Archives of Physical Medicine and Rehabilitation. 1990 Jan 1
• 31 citations
  The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer's disease or stroke as measured by single-photon emission computed tomography.
  Frederick J. Bonte, Michael D. Devous, Joan S. Reisch, Ajay K. Ajmani, Jim Hom, Ron Tintner, Myron F. Weiner> ;Investigative Radiology. 1989 Feb 1
• 33 citations
  Neuropathologic verification of Creutzfeldt‐Jakob disease in the exhumed American recipient of human pituitary growth hormone: Epidemiologic and pathogenetic implications
  Ron Tintner, P. Brown, E. T. Hedley-Whyte, E. B. Rappaport, C. P. Piccardo, D. C. Gajdusek> ;Neurology. 1986 Jul 1
• 8 citations
  Corticotrophin increases cerebral polyamine content.
  Ron Tintner, Adrian J. Dunn, P. Michael Iuvone, Jayesh B. Shukla, Owen M. Rennert> ;Journal of Neurochemistry. 1979 Nov 1
• 81 citations
  Behavioral responses to intracerebroventricularly administered neurohypophyseal peptides in mice
  Richard L. Delanoy, Adrian J. Dunn, Ron Tintner> ;Hormones and Behavior. 1978 Dec 1
• Brain blood flow in the dementias: SPECT with histopathologic correlation.
  Bonte, F. J., Tintner, R., Weiner, M. F., Bigio, E. H., White, C. L.> ;Radiology. 1993 Feb
• Join now to see all